英文摘要 |
The heart is a vital organ for human beings, and its regular rhythmicperformance ensures the proper functioning of the body. Clinical physicianswere concerned about heart pacing disorder-related diseases until 1958, when thefirst pacemaker in medical history was utilized. More than four million peoplehave received cardiac implantable electronic devices (CIEDs) after rapid cardiacdisease development and intervention over the past half century. However, cardiacimplantable electronic device infections brought upon other medical issues. Thecrude incidence of CIED infection is 1.5-2.4%, and electronic device infectionsmay be attributed to patient factors, device types, and the number of devicerelatedinterventions. The significant risk factors for patient comorbidities aremedical illness, renal failure, heart failure, diabetes, usage of anti-coagulant agents,and steroids. Gram-positive bacteria are usually the cause of infection, of whichStaphylococcus aureus is the most common. Clinical manifestations include skinreddening, warmth, edema, pain, purulent discharge, and erosion, and sometimes,severe sepsis and infective endocarditis. Conservative medical therapy may controllocalized infection, usually after 7-14 days of antimicrobial agent use. Systemicinfections require removal of the electronic device and longer durations of antiinfectiontherapy. Strategies to prevent device infections have been proposed, suchas pre-procedure prophylaxis antimicrobial agents, antimicrobial agent-coveredenvelopes for electronic devices, and measures to decrease the growth of postprocedurehematomas. |